Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Regulatory News (FUM)

Share Price Information for Futura Medical (FUM)

Share Price is delayed by 15 minutes
Get Live Data
0.54    0.01 (1.89%)
Bid:
0.52
Ask:
0.598
Spread: 0.078 (15.00%)
Market Cap: £3.14m
FUM Live PriceLast checked at - London Stock Exchange

Intraday Futura Medical Share Chart

Board Appointment

24 Sep 2008 07:00

RNS Number : 1282E
Futura Medical PLC
24 September 2008
 



For immediate release 

24 September 2008

Futura Medical plc

("Futura" or "the Group" or "the Company")

Appointment of Finance Director

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, is pleased to announce that Derek Martin, who joined Futura as Financial Controller in April 2007, has been appointed to the Board of Futura as Finance Director with immediate effect

Derek Adrian Martin, age 47, is a chartered accountant with a breadth of experience gained across a number of sectors, including technology and retail, at private and publicly quoted companies of varying sizes.

Prior to joining Futura, Mr Martin was a financial controller at Thales.  Between 2005 and 2007 he was financial controller at Links of London Limited, the jewellery chain, before its disposal to Folli Follie, and between 2001 and 2005 he was financial controller at Entuity Limited, a US software company. Mr Martin gained AIM experience in the role of financial controller at World Telecom plc, between 1996 and 2001, prior to the company's sale to Torc Telecom Limited.

James Barder, Futura's Chief Executive, said: "I am delighted to welcome Derek to the role of Finance Director and to Futura's Board. He has worked at Futura in the role of Financial Controller since April 2007 and has proved himself to be a highly competent finance executive. I look forward to his contribution to Futura's Board."

There are no further disclosures to be made in accordance with Schedule 2 (g) of the AIM rules.

For any further information please contact:

Futura Medical plc

James Barder, Chief Executive

Tel: +44 (0) 1483 685 670

mail to: james.barder@futuramedical.co.uk

www.futuramedical.co.uk 

Canaccord Adams

Ryan Gaffney / Adria Da Breo Richards

Tel: +44 (0) 20 7050 6500 

For media enquiries please contact: 

Buchanan Communications

Mark Court / Rebecca Skye Dietrich

Tel: +44 (0) 20 7466 5000

 

  

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAQXLFLVKBBBBF
Date   Source Headline
6th May 20224:41 pmRNSSecond Price Monitoring Extn
6th May 20224:35 pmRNSPrice Monitoring Extension
26th Apr 20227:00 amRNSFull Year Results 2021
14th Apr 20223:54 pmRNSFutura Medical Notice of Preliminary Results 2021
11th Apr 20224:28 pmRNSTR-1: Notification of major holdings
1st Apr 20224:58 pmRNSTR-1: Notification of major holdings
23rd Mar 20227:00 amRNSFutura Announces Collaboration with Menarini
2nd Feb 20225:30 pmRNSTR-1:Notification of major holdings
13th Jan 202210:32 amRNSRemuneration of Non-Executive Directors and TVR
20th Dec 20217:00 amRNSUS regulatory and commercial update for MED3000
2nd Dec 202112:02 pmRNSTR-1: Notification of major holdings
30th Nov 20217:00 amRNSBlock Listing Six Monthly Return
30th Nov 20217:00 amRNSFutura Medical plc Total Voting Rights
28th Oct 20217:00 amRNSFutura Medical plc Board Appointment
8th Oct 20217:00 amRNSFutura Medical plc Board Appointment
5th Oct 20214:05 pmRNSDirector/PDMR Shareholding
29th Sep 20217:00 amRNSInterim Results for Six Months ended 30 June 2021
27th Sep 20217:00 amRNSFutura Announces Collaboration with Labatec Pharma
17th Sep 20217:00 amRNSNotice of Interim Results
15th Sep 20217:00 amRNSFirst Patient visit in MED3000 Confirmatory Study
8th Sep 20213:49 pmRNSTR1: Notification of Major Holdings
31st Aug 20217:00 amRNSFutura Medical Announces Collaboration of MED3000
19th Jul 20217:00 amRNSFDA regulatory and commercial update for MED3000
28th Jun 20211:26 pmRNSResult of AGM
28th Jun 20217:00 amRNSAGM Statement
25th Jun 20212:55 pmRNSTR1: Notification of Major Holdings
15th Jun 20213:48 pmRNSTR-1: Notification of major holdings
9th Jun 20213:58 pmRNSTR-1: Notification of major holdings
3rd Jun 20214:19 pmRNSTR-1: Notification of major holdings
3rd Jun 202111:00 amRNSNotice of AGM and Annual Report
2nd Jun 202112:50 pmRNSResult of General Meeting & Total Voting Rights
1st Jun 20217:00 amRNSBlock Listing Six Monthly Return
17th May 20213:08 pmRNSPosting of Circular and Notice of General Meeting
17th May 20217:00 amRNSResult of Placing and Retail Offer
14th May 20214:41 pmRNSSecond Price Monitoring Extn
14th May 20214:35 pmRNSPrice Monitoring Extension
14th May 20214:31 pmRNSRetail Offer by PrimaryBid
14th May 20214:30 pmRNSProposed Placing to raise £10 mil & Retail Offer
4th May 20215:18 pmRNSTR-1: Notification of major holdings
4th May 20215:15 pmRNSTR-1: Notification of major holdings
4th May 20217:00 amRNSTotal Voting Rights
30th Apr 20217:00 amRNSFutura Receives Approval from EU Notified Body
28th Apr 20212:57 pmRNSTR-1: Notification of major holdings
28th Apr 20219:31 amRNSTR-1: Notification of major holdings
22nd Apr 20214:58 pmRNSTR-1: Notification of major holdings
19th Apr 20214:03 pmRNSCorrection – Conversion of Convertible Loan Notes
15th Apr 20212:42 pmRNSConversion of Convertible Loan Notes
14th Apr 20213:40 pmRNSRemuneration of Non-Executive Directors and TVR
14th Apr 20217:00 amRNSFull Year Results for the year ended 31 Dec 2020
1st Apr 20214:20 pmRNSExercise of Warrants, Issue of Equity & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.